Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach

Abstract Cervical cancer is the fourth most common cancer in women worldwide. Increasing evidence has shown that miRNAs are related to the progression of cervical cancer. However, the mechanisms that affect the prognosis of cancer are still largely unknown. In the present study, we sought to identif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yumei Qi, Yo-Liang Lai, Pei-Chun Shen, Fang-Hsin Chen, Li-Jie Lin, Heng-Hsiung Wu, Pei-Hua Peng, Kai-Wen Hsu, Wei-Chung Cheng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/12a635dbd4f94295b89f26b127f24e09
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:12a635dbd4f94295b89f26b127f24e09
record_format dspace
spelling oai:doaj.org-article:12a635dbd4f94295b89f26b127f24e092021-12-02T13:58:10ZIdentification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach10.1038/s41598-020-79337-42045-2322https://doaj.org/article/12a635dbd4f94295b89f26b127f24e092020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79337-4https://doaj.org/toc/2045-2322Abstract Cervical cancer is the fourth most common cancer in women worldwide. Increasing evidence has shown that miRNAs are related to the progression of cervical cancer. However, the mechanisms that affect the prognosis of cancer are still largely unknown. In the present study, we sought to identify miRNAs associated with poor prognosis of patient with cervical cancer, as well as the possible mechanisms regulated by them. The miRNA expression profiles and relevant clinical information of patients with cervical cancer were obtained from The Cancer Genome Atlas (TCGA). The selection of prognostic miRNAs was carried out through an integrated bioinformatics approach. The most effective miRNAs with synergistic and additive effects were selected for validation through in vitro experiments. Three miRNAs (miR-216b-5p, miR-585-5p, and miR-7641) were identified as exhibiting good performance in predicting poor prognosis through additive effects analysis. The functional enrichment analysis suggested that not only pathways traditionally involved in cancer but also immune system pathways might be important in regulating the outcome of the disease. Our findings demonstrated that a synergistic combination of three miRNAs may be associated, through their regulation of specific pathways, with very poor survival rates for patients with cervical cancer.Yumei QiYo-Liang LaiPei-Chun ShenFang-Hsin ChenLi-Jie LinHeng-Hsiung WuPei-Hua PengKai-Wen HsuWei-Chung ChengNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yumei Qi
Yo-Liang Lai
Pei-Chun Shen
Fang-Hsin Chen
Li-Jie Lin
Heng-Hsiung Wu
Pei-Hua Peng
Kai-Wen Hsu
Wei-Chung Cheng
Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
description Abstract Cervical cancer is the fourth most common cancer in women worldwide. Increasing evidence has shown that miRNAs are related to the progression of cervical cancer. However, the mechanisms that affect the prognosis of cancer are still largely unknown. In the present study, we sought to identify miRNAs associated with poor prognosis of patient with cervical cancer, as well as the possible mechanisms regulated by them. The miRNA expression profiles and relevant clinical information of patients with cervical cancer were obtained from The Cancer Genome Atlas (TCGA). The selection of prognostic miRNAs was carried out through an integrated bioinformatics approach. The most effective miRNAs with synergistic and additive effects were selected for validation through in vitro experiments. Three miRNAs (miR-216b-5p, miR-585-5p, and miR-7641) were identified as exhibiting good performance in predicting poor prognosis through additive effects analysis. The functional enrichment analysis suggested that not only pathways traditionally involved in cancer but also immune system pathways might be important in regulating the outcome of the disease. Our findings demonstrated that a synergistic combination of three miRNAs may be associated, through their regulation of specific pathways, with very poor survival rates for patients with cervical cancer.
format article
author Yumei Qi
Yo-Liang Lai
Pei-Chun Shen
Fang-Hsin Chen
Li-Jie Lin
Heng-Hsiung Wu
Pei-Hua Peng
Kai-Wen Hsu
Wei-Chung Cheng
author_facet Yumei Qi
Yo-Liang Lai
Pei-Chun Shen
Fang-Hsin Chen
Li-Jie Lin
Heng-Hsiung Wu
Pei-Hua Peng
Kai-Wen Hsu
Wei-Chung Cheng
author_sort Yumei Qi
title Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
title_short Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
title_full Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
title_fullStr Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
title_full_unstemmed Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
title_sort identification and validation of a mirna-based prognostic signature for cervical cancer through an integrated bioinformatics approach
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/12a635dbd4f94295b89f26b127f24e09
work_keys_str_mv AT yumeiqi identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT yolianglai identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT peichunshen identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT fanghsinchen identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT lijielin identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT henghsiungwu identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT peihuapeng identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT kaiwenhsu identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
AT weichungcheng identificationandvalidationofamirnabasedprognosticsignatureforcervicalcancerthroughanintegratedbioinformaticsapproach
_version_ 1718392242817728512